Building a leading microbiome

company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

November 13, 2023

November 13, 2023: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

November 9, 2023

November 9, 2023: MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results

November 6, 2023

November 6, 2023: MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

Like what you see? See more posts

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!